These luminal B cancers exhibited higher activity of pathways associated with the ECM-regulated Hippo pathway and immune tolerance, including mRNAs encoding checkpoint inhibitor molecules (IDO1, PD1, LAG3) and increased IFNγ-STAT1 signaling [69]. Here, IDO1 is linked to cancer.